Informaçao sobre o Autor

Ostroumova, Olga D.

Edição Seção Título Arquivo
Volume 26, Nº 4 (2019) Articles Potential drug interactions of oral hypoglycemic drugs that increase the risk of hypoglycemia
Volume 26, Nº 14 (2019) Articles Hypoglycemic drugs and drug-induced heart failure
Volume 26, Nº 14 (2019) Articles Drug-induced hyperthyroidism
Volume 27, Nº 2 (2020) Articles Medicines associated with the development of drug-induced constipation
Volume 27, Nº 4 (2020) Articles Individual drugs associated with overweight inducing
Volume 27, Nº 4 (2020) Articles Medicines associated with the development of osteoporosis
Volume 27, Nº 3 (2020) Articles Approaches to choosing a direct oral anticoagulant in the treatment of polymorbid patients with atrial fibrillation
Volume 27, Nº 3 (2020) Articles The benefits of fixed combinations for the treatment of arterial hypertension in women with menopausal disorders: focus on Gipotef
Volume 27, Nº 5 (2020) Articles Drug-induced diseases: epidemiology and urgency of the problem
Volume 27, Nº 6 (2020) Articles Drug-induced diseases: approaches to diagnosis, correction and prevention. Pharmacovigilance
Volume 28, Nº 3 (2021) Articles The relationship of cardiovascular disease with increased intestinal permeability: results from scientific and controlled clinical trials. Focus on the potential of rebamipide
Volume 28, Nº 3 (2021) Articles The choice of antianginal therapy for polymordib patients with coronary artery disease and type 2 diabetes mellitus: the benefits of trimetazidine
Volume 28, Nº 5 (2021) Articles Tobacco smoking as a risk factor for the development of drug-induced diseases
Volume 28, Nº 11 (2021) Articles Medication errors as risk factor for drug-induced diseases
Volume 28, Nº 12 (2021) Articles Risk factors of drug-induced diseases. Part 2. Comorbid diseases and lifestyle factors
Volume 29, Nº 1 (2022) Articles Risk factors of drug-induced diseases. Part 3. Drug-drug and drug-food interactions
Volume 29, Nº 3 (2022) Articles Risk factors of drug-induced diseases. Part 4. Medication errors and patient adherence
Volume 29, Nº 11/12 (2022) Articles Drugs, the use of which is associated with the development of drug-induced kidney stone disease. Part 2
Volume 29, Nº 13 (2022) Articles Controversial and unresolved aspects of drug-induced hemorrhagic stroke: focus on selective serotonin reuptake inhibitors, non-steroidal anti-inflammatory drugs and statins
Volume 29, Nº 13 (2022) Articles Structure of prescription of gastroprotective drugs in patients receiving direct oral anticoagulants: results of a multicenter cross-sectional pharmacoepidemiological study
Volume 30, Nº 14 (2023) Cardiology On the issue of improving the safety of antithrombotic therapy in patients with atrial fibrillation and coronary heart disease receiving antithrombotic therapy
Volume 31, Nº 1 (2024) Cardiology On the possible relationship between the presence of polymorphic variants of CYP3A4/5 cytochrome genes, their metabolic activity with rivaroxaban pharmacokinetics and the development of bleeding in patients with non-valvular atrial fibrillation and chronic kidney disease
Volume 31, Nº 1 (2024) Cardiology Arterial hypertension and cognitive impairment in elderly and senile patients: basic approaches to patient management
Volume 31, Nº 1 (2024) Cardiology State of cognitive functions in patients with various forms of atrial fibrillation

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies